Status:
COMPLETED
The Effects of Intravenous Dexmedetomidine on Spinal Anesthesia Using Low Dose Diluted Bupivacaine for Transurethral Resection of Prostate
Lead Sponsor:
Yonsei University
Conditions:
Transurethral Prostatectomy
Eligibility:
MALE
20+ years
Phase:
NA
Brief Summary
Dexmedetomidine is a new selective and potent alpha-2 agonist. It has centrally acting anesthetic properties. It has been known that intrathecal addition of alpha-2 adrenergic agents result in prolong...
Eligibility Criteria
Inclusion
- ASA class I or II
- Elective transurethral prostatectomy
- aged \> 20
Exclusion
- Coagulation deficiency
- infection on the back
- Congestive heart failure or arrythmia
- Chronic alcoholic disease
- Antidepressants therapy
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01224470
Start Date
November 1 2010
End Date
February 1 2011
Last Update
April 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, South Korea, 120-752